Patents by Inventor Michael Rosinko

Michael Rosinko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911590
    Abstract: A system and method can provide for a remote electronic device to be used to remotely initiate delivery of a medicament bolus with a medical device, such as an insulin pump, with the medical device providing audible or tactile confirmation of the programmed bolus. The bolus amount can be calculated by or programmed or otherwise entered into the smartphone, etc., and then transmitted to the medical device. When the pump receives the transmitted bolus amount, it issues one or more indications such as audible sounds and/or vibrations in any number of desired combinations. For instance, each individual sound or vibration may correspond to an increment of the medicament. The user can therefore determine the size of the medicament bolus by the number of sounds or vibrations and can confirm or cancel delivery of the bolus.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: February 27, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Rosinko
  • Publication number: 20240062867
    Abstract: Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.
    Type: Application
    Filed: December 17, 2021
    Publication date: February 22, 2024
    Applicant: Beta Bionics, Inc.
    Inventors: David Chi-Wai Lim, Firas El-Khatib, Himanshu Patel, Michael Rosinko, David Henderson, Justin Brown
  • Publication number: 20230191027
    Abstract: A portable insulin pump can integrate and display data from a continuous glucose monitor (CGM) to allow a user to more readily determine whether any interaction with the pump is necessary. Data from the CGM can automatically be transmitted to the pump and can be displayed for user analysis or automatically analyzed to present recommendations to the user based on combined data from the CGM and the pump.
    Type: Application
    Filed: February 13, 2023
    Publication date: June 22, 2023
    Inventors: Michael Rosinko, Sean Saint, Jason Farnan, Shaun Buchanan
  • Patent number: 11607492
    Abstract: A portable insulin pump can integrate and display data from a continuous glucose monitor (CGM) to allow a user to more readily determine whether any interaction with the pump is necessary. Data from the CGM can automatically be transmitted to the pump and can be displayed for user analysis or automatically analyzed to present recommendations to the user based on combined data from the CGM and the pump.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: March 21, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Rosinko, Sean Saint, Jason Farnan, Shaun Buchanan
  • Publication number: 20220257876
    Abstract: A portable insulin pump can utilize readings from a sensor incorporated into an infusion set used with the pump to deliver insulin to a patient to determine if the infusion set is or is likely to become dislodged from the patient. Readings from the sensor that are inconsistent with expected readings or a range of expected readings can indicate that the infusion set has become dislodged from the patient.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 18, 2022
    Inventor: Michael Rosinko
  • Patent number: 11324898
    Abstract: A portable insulin pump can utilize readings from a sensor incorporated into an infusion set used with the pump to deliver insulin to a patient to determine if the infusion set is or is likely to become dislodged from the patient. Readings from the sensor that are inconsistent with expected readings or a range of expected readings can indicate that the infusion set has become dislodged from the patient.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: May 10, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Rosinko
  • Publication number: 20210146041
    Abstract: A system and method can provide for a remote electronic device to be used to remotely initiate delivery of a medicament bolus with a medical device, such as an insulin pump, with the medical device providing audible or tactile confirmation of the programmed bolus. The bolus amount can be calculated by or programmed or otherwise entered into the smartphone, etc., and then transmitted to the medical device. When the pump receives the transmitted bolus amount, it issues one or more indications such as audible sounds and/or vibrations in any number of desired combinations. For instance, each individual sound or vibration may correspond to an increment of the medicament. The user can therefore determine the size of the medicament bolus by the number of sounds or vibrations and can confirm or cancel delivery of the bolus.
    Type: Application
    Filed: January 26, 2021
    Publication date: May 20, 2021
    Inventor: Michael Rosinko
  • Publication number: 20210093782
    Abstract: A portable infusion pump can communicate with glucose monitor, such as a continuous glucose monitor (CGM), to receive continuous feedback relating to a user's blood glucose level during insulin or other medicament therapy and can automatically deliver insulin to a user when the CGM data indicates a need for additional insulin. Due to potential unreliability in the correlation of the CGM data to the user's actual blood glucose level, risk mitigation can be employed to limit the amount of extra insulin that can be delivered by the pump in response to the CGM data.
    Type: Application
    Filed: December 14, 2020
    Publication date: April 1, 2021
    Inventors: Sean Saint, Michael Rosinko
  • Patent number: 10918785
    Abstract: A system and method can provide for a remote electronic device to be used to remotely initiate delivery of a medicament bolus with a medical device, such as an insulin pump, with the medical device providing audible or tactile confirmation of the programmed bolus. The bolus amount can be calculated by or programmed or otherwise entered into the smartphone, etc., and then transmitted to the medical device. When the pump receives the transmitted bolus amount, it issues one or more indications such as audible sounds and/or vibrations in any number of desired combinations. For instance, each individual sound or vibration may correspond to an increment of the medicament. The user can therefore determine the size of the medicament bolus by the number of sounds or vibrations and can confirm or cancel delivery of the bolus.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: February 16, 2021
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Rosinko
  • Publication number: 20210001038
    Abstract: A system and method provide for enhanced reliability and safety of programming and/or operating a medical device, such as an infusion pump.
    Type: Application
    Filed: September 17, 2020
    Publication date: January 7, 2021
    Inventor: Michael Rosinko
  • Patent number: 10864322
    Abstract: A portable infusion pump can communicate with glucose monitor, such as a continuous glucose monitor (CGM), to receive continuous feedback relating to a user's blood glucose level during insulin or other medicament therapy and can automatically deliver insulin to a user when the CGM data indicates a need for additional insulin. Due to potential unreliability in the correlation of the CGM data to the user's actual blood glucose level, risk mitigation can be employed to limit the amount of extra insulin that can be delivered by the pump in response to the CGM data.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: December 15, 2020
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Sean Saint, Michael Rosinko
  • Patent number: 10806851
    Abstract: A system and method provide for enhanced reliability and safety of programming and/or operating a medical device, such as an infusion pump, with a remote control device, such as a mobile phone (e.g., a smartphone) can determine whether the smartphone is compatible with the medical device by checking the type and version of the smartphone as well as the versions of the operating software and/or firmware resident on the phone.
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: October 20, 2020
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Rosinko
  • Publication number: 20200171249
    Abstract: A portable insulin pump can utilize readings from a sensor incorporated into an infusion set used with the pump to deliver insulin to a patient to determine if the infusion set is or is likely to become dislodged from the patient. Readings from the sensor that are inconsistent with expected readings or a range of expected readings can indicate that the infusion set has become dislodged from the patient.
    Type: Application
    Filed: February 4, 2020
    Publication date: June 4, 2020
    Inventor: Michael Rosinko
  • Patent number: 10653828
    Abstract: A portable medical device includes an interface for accepting a power supply and enabling data transfer while still connected to a human body. The interface may include a universal serial bus interface and may be coupled to a data isolation chip and a power isolation chip. A power controlling processor may determine how the supplied power, e.g., voltage, is supplied to other components within the infusion device. Additional circuitry within the system may provide a secure power transfer within the device to ensure user safety and ensure that a high frequency noise is properly attenuated.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: May 19, 2020
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Justin Brown, Donald Ludolph, Phil Lamb, Anthony Barghini, Sean Saint, Marcus Julian, Robert Eastridge, Michael Rosinko, Michael Michaud
  • Publication number: 20200101226
    Abstract: A portable insulin pump can integrate and display data from a continuous glucose monitor (CGM) to allow a user to more readily determine whether any interaction with the pump is necessary. Data from the CGM can automatically be transmitted to the pump and can be displayed for user analysis or automatically analyzed to present recommendations to the user based on combined data from the CGM and the pump.
    Type: Application
    Filed: October 2, 2019
    Publication date: April 2, 2020
    Inventors: Michael Rosinko, Sean Saint, Jason Farnan, Shaun Buchanan
  • Patent number: 10549051
    Abstract: A portable insulin pump can utilize readings from a sensor incorporated into an infusion set used with the pump to deliver insulin to a patient to determine if the infusion set is or is likely to become dislodged from the patient. Readings from the sensor that are inconsistent with expected readings or a range of expected readings can indicate that the infusion set has become dislodged from the patient.
    Type: Grant
    Filed: January 15, 2018
    Date of Patent: February 4, 2020
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Rosinko
  • Publication number: 20200012401
    Abstract: A portable medical device is operated in an active mode in which the device receives a user input at an input interface and provides the received user input to a processor of the device. The active mode is terminated and the device is operated in a safe mode, in which the received user input is not provided to the processor and/or one or more device function is disabled, in response to determining that the received user input was received in an out of bounds region of the input interface. The safe mode is terminated in response to receiving a predetermined user input comprising an activation input.
    Type: Application
    Filed: September 17, 2019
    Publication date: January 9, 2020
    Inventors: Michael Rosinko, Geoff Kruse, Thomas Ulrich, Erik Verhoef
  • Patent number: 10478551
    Abstract: A system and method can provide for a remote electronic device to be used to remotely initiate delivery of a medicament bolus with a medical device, such as an insulin pump, with the medical device providing audible or tactile confirmation of the programmed bolus. The bolus amount can be calculated by or programmed or otherwise entered into the smartphone, etc., and then transmitted to the medical device. When the pump receives the transmitted bolus amount, it issues one or more indications such as audible sounds and/or vibrations in any number of desired combinations. For instance, each individual sound or vibration may correspond to an increment of the medicament. The user can therefore determine the size of the medicament bolus by the number of sounds or vibrations and can confirm or cancel delivery of the bolus.
    Type: Grant
    Filed: July 19, 2017
    Date of Patent: November 19, 2019
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Rosinko
  • Publication number: 20190298915
    Abstract: A system and method can provide for a remote electronic device to be used to remotely initiate delivery of a medicament bolus with a medical device, such as an insulin pump, with the medical device providing audible or tactile confirmation of the programmed bolus. The bolus amount can be calculated by or programmed or otherwise entered into the smartphone, etc., and then transmitted to the medical device. When the pump receives the transmitted bolus amount, it issues one or more indications such as audible sounds and/or vibrations in any number of desired combinations. For instance, each individual sound or vibration may correspond to an increment of the medicament. The user can therefore determine the size of the medicament bolus by the number of sounds or vibrations and can confirm or cancel delivery of the bolus.
    Type: Application
    Filed: June 18, 2019
    Publication date: October 3, 2019
    Inventor: Michael Rosinko
  • Patent number: D938457
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: December 14, 2021
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Rosinko, Sean Saint, Jason Farnan, Shaun Buchanan